New SEC Form D filing

Vesalius Longevity Labs Inc., 2026-11-18

A new SEC Form D private-offering notice from Vancouver, BC, Canada, a $13,464,278 filer-stated offering target in Biotech. The source filing is one click away.

What this filing says

Vesalius Longevity Labs Inc. site↗ Verified via SEC Form D

Peptide based longevity and clinical healthcare platform connecting licensed prescribers with pharmacies to dispense patient specific peptide prescriptions

New filing yesterdayFiled to raise $13,464,278First money in 2026-11-06Raised so far $6,499,999HQ (as filed) Vancouver, BC, CanadaSector Biotech web-verified against the company’s own siteStage (inferred) EarlyCall status Non-US principal office
Source linked the Form D on EDGAR↗Website verified vesaliuslabs.com↗Named in the filing 10 executives & directors

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source